Deep learning has been reported to achieve high performances in the detection of skin cancer, yet many challenges regarding the reproducibility of results and biases remain. This study is a replication (different data, same analysis) of a previous study on Alzheimer's disease detection, which studied the robustness of logistic regression (LR) and convolutional neural networks (CNN) across patient sexes. We explore sex bias in skin cancer detection, using the PAD-UFES-20 dataset with LR trained on handcrafted features reflecting dermatological guidelines (ABCDE and the 7-point checklist), and a pre-trained ResNet-50 model. We evaluate these models in alignment with the replicated study: across multiple training datasets with varied sex composition to determine their robustness. Our results show that both the LR and the CNN were robust to the sex distribution, but the results also revealed that the CNN had a significantly higher accuracy (ACC) and area under the receiver operating characteristics (AUROC) for male patients compared to female patients. The data and relevant scripts to reproduce our results are publicly available (https://github.com/

Skin cancer is one of the most prevalent and preventable types of cancer, yet its early detection remains a challenge, particularly in resource-limited settings where access to specialized healthcare is scarce. This study proposes an AI-driven diagnostic tool optimized for embedded systems to address this gap. Using transfer learning with the MobileNetV2 architecture, the model was adapted for binary classification of skin lesions into "Skin Cancer" and "Other." The TensorRT framework was employed to compress and optimize the model for deployment on the NVIDIA Jetson Orin Nano, balancing performance with energy efficiency. Comprehensive evaluations were conducted across multiple benchmarks, including model size, inference speed, throughput, and power consumption. The optimized models maintained their performance, achieving an F1-Score of 87.18% with a precision of 93.18% and recall of 81.91%. Post-compression results showed reductions in model size of up to 0.41, along with improvements in inference speed and throughput, and a decrease in energy consumption of up to 0.93 in INT8 precision. These findings validate the feasibility of deploying high-performing, energy-efficient diagnostic tools on resource-constrained edge devices. Beyond skin cancer detection, the methodologies applied in this research have broader applications in other medical diagnostics and domains requiring accessible, efficient AI solutions. This study underscores the potential of optimized AI systems to revolutionize healthcare diagnostics, thereby bridging the divide between advanced technology and underserved regions.

The rapid advancement of deep learning in medical image analysis has greatly enhanced the accuracy of skin cancer classification. However, current state-of-the-art models, especially those based on transfer learning like ResNet50, come with significant computational overhead, rendering them impractical for deployment in resource-constrained environments. This study proposes a custom CNN model that achieves a 96.7\% reduction in parameters (from 23.9 million in ResNet50 to 692,000) while maintaining a classification accuracy deviation of less than 0.022\%. Our empirical analysis of the HAM10000 dataset reveals that although transfer learning models provide a marginal accuracy improvement of approximately 0.022\%, they result in a staggering 13,216.76\% increase in FLOPs, considerably raising computational costs and inference latency. In contrast, our lightweight CNN architecture, which encompasses only 30.04 million FLOPs compared to ResNet50's 4.00 billion, significantly reduces energy consumption, memory footprint, and inference time. These findings underscore the trade-off between the complexity of deep models and their real-world feasibility, positioning our optimized CNN as a practical solution for mobile and edge-based skin cancer diagnostics.

Skin cancer is a serious and potentially fatal disease caused by DNA damage. Early detection significantly increases survival rates, making accurate diagnosis crucial. In this groundbreaking study, we present a hybrid framework based on Deep Learning (DL) that achieves precise classification of benign and malignant skin lesions. Our approach begins with dataset preprocessing to enhance classification accuracy, followed by training two separate pre-trained DL models, InceptionV3 and DenseNet121. By fusing the results of each model using the weighted sum rule, our system achieves exceptional accuracy rates. Specifically, we achieve a 92.27% detection accuracy rate, 92.33% sensitivity, 92.22% specificity, 90.81% precision, and 91.57% F1-score, outperforming existing models and demonstrating the robustness and trustworthiness of our hybrid approach. Our study represents a significant advance in skin cancer diagnosis and provides a promising foundation for further research in the field. With the potential to save countless lives through earlier detection, our hybrid deep-learning approach is a game-changer in the fight against skin cancer.

Skin cancer detection through dermoscopy image analysis is a critical task. However, existing models used for this purpose often lack interpretability and reliability, raising the concern of physicians due to their black-box nature. In this paper, we propose a novel approach for the diagnosis of melanoma using an interpretable prototypical-part model. We introduce a guided supervision based on non-expert feedback through the incorporation of: 1) binary masks, obtained automatically using a segmentation network; and 2) user-refined prototypes. These two distinct information pathways aim to ensure that the learned prototypes correspond to relevant areas within the skin lesion, excluding confounding factors beyond its boundaries. Experimental results demonstrate that, even without expert supervision, our approach achieves superior performance and generalization compared to non-interpretable models.

Skin cancer is a major public health problem around the world. Its early detection is very important to increase patient prognostics. However, the lack of qualified professionals and medical instruments are significant issues in this field. In this context, over the past few years, deep learning models applied to automated skin cancer detection have become a trend. In this paper, we present an overview of the recent advances reported in this field as well as a discussion about the challenges and opportunities for improvement in the current models. In addition, we also present some important aspects regarding the use of these models in smartphones and indicate future directions we believe the field will take.

Skin cancer is one of the most common types of cancer around the world. For this reason, over the past years, different approaches have been proposed to assist detect it. Nonetheless, most of them are based only on dermoscopy images and do not take into account the patient clinical information. In this work, first, we present a new dataset that contains clinical images, acquired from smartphones, and patient clinical information of the skin lesions. Next, we introduce a straightforward approach to combine the clinical data and the images using different well-known deep learning models. These models are applied to the presented dataset using only the images and combining them with the patient clinical information. We present a comprehensive study to show the impact of the clinical data on the final predictions. The results obtained by combining both sets of information show a general improvement of around 7% in the balanced accuracy for all models. In addition, the statistical test indicates significant differences between the models with and without considering both data. The improvement achieved shows the potential of using patient clinical information in skin cancer detection and indicates that this piece of information is important to leverage skin cancer detection systems.

The same technology that suggests friends for you to tag in photos on social media could provide an exciting new tool to help dermatologists diagnose skin cancer. While artificial intelligence systems for skin cancer detection have shown promise in research settings, however, there is still a lot of work to be done before the technology is appropriate for real-world use. "AI systems for skin cancer detection are still in their very early stages," says board-certified dermatologist Roger S. Ho, MD, MPH, FAAD, assistant professor in the Ronald O. Perelman Department of Dermatology at NYU Langone Health in New York. "Nothing is 100 percent clear-cut yet." One murky area is the skin cancer "scores" that AI algorithms assign to suspicious spots.

Created by FotoFinder Systems, Moleanalyzer pro is a portal that lets physicians confirm their skin cancer diagnosis using evaluation techniques, combining specialist expertise with AI and including the option of receiving a second opinion from international skin cancer experts. FotoFinder Systems Global Brand Director Kathrin Niemela told HITNA that the technology aims to aid skin cancer diagnoses. According to the Cancer Council Australia, every year skin cancers account for around 80 per cent of all newly diagnosed cancers in Australia, with GPs seeing more than a million patients per year for skin cancer. In addition, the Australian Government identified that there were 14,320 new cases of melanoma skin cancer diagnosed in 2018, accounting for 10.4 per cent of all new cancer cases diagnosed. "The earlier skin cancer is detected, the better the prognosis. The leisure behaviour of sunbathing in many parts of the world makes early detection of skin cancer more important worldwide," Niemela said.

Engineers participating in a hackathon last weekend demonstrated an artificial intelligence that they say could someday detect cancerous moles, TechCrunch reports. Although the program is currently in its infancy, the team hopes that enough user submissions could allow Doctor Hazel to predict skin cancer with at least 90 percent accuracy. After one day and thousands of image downloads, the AI is identifying cancer at an 85 percent success rate, the team said during a presentation at TechCrunch Disrupt's San Francisco 2017 hackathon. However, the team has launched a beta and is inviting users to submit their own photos to improve Doctor Hazel's performance. "There's a huge problem in getting AI data for medicine … no one wants to share," Mike Borozdin, developer of Doctor Hazel, told TechCrunch.